Global Periodontal Therapeutics Market - 2023-2030

Periodontal Therapeutics The Global Periodontal Therapeutics Market size reached US$ 734.8 million in 2022 and is projected to witness lucrative growth by reaching up to US$ 1,459.3 million by 2031. The periodontal therapeutics market is growing at a CAGR of 9.2% during the forecast period 2024-2031.

Teledentistry is one of the options that reduce the time taken by employees to see dental providers in person. Though appointments can take hours out of an employee’s work day, only 17 percent (20 minutes) of that time is spent at the doctors.

They can be cost-effective for patients while guaranteeing more revenue for dental practices. Thus the growing trend of teledentistry is driving the periodontal therapeutics market growth in the forecast period.

The global periodontal therapeutics market is expected to witness significant growth in the coming years owing to the rising incidence of periodontal diseases, such as periodontitis and gingivitis, which are leading causes of tooth loss among adults worldwide. Periodontal disease, also known as gum disease, is characterized by inflammation and infection of the gums surrounding the teeth; and is a major dental health concern globally.

As a result, the demand for effective treatment options is increasing, thereby fueling the growth of the global periodontal therapeutics market.

Periodontal Therapeutics Market Dynamics

The Increasing Prevalence of Periodontal Diseases is Driving the Market Growth

The growing prevalence of periodontal diseases such as periodontitis and gingivitis is the primary factor driving the growth of the global periodontal therapeutics market. Periodontitis is considered one of the major oral diseases considering the rate of infection among the population and its overall effect on overall health.

For instance, according to World Health Organization (WHO), approximately 19% of the global population, which is about 1 billion people are affected by severe periodontal (gum) disease by 2023. This is due to poor oral hygiene and consumption of tobacco use. Owing to these factors, the global periodontal therapeutics market will escalate for the forecast period

Rising R&D Investments Open Lucrative Opportunities for Global Periodontal Therapeutics Market Growth

The ongoing research on the use of herbal medicine in the treatment of periodontitis is likely to provide new growth avenues for the periodontal therapeutics market. Several botanical drugs reportedly with antimicrobial, anti-inflammatory and anti-collagenase properties are under consideration for use in treating periodontitis.

For example, AngioLab’s AL201-AB is a botanical drug that inhibits tooth loss by inhibiting MMP-1, -8, -9, and -13. It is under phase-2 clinical trials in 2020 as a periodontal therapeutic. Therefore these developments in the research will fuel the global periodontal therapeutics market for the forecast period.

The Utilization of Surgical Procedures is the Restraining Factor for the Market Growth

Combination therapies are still in the early stages of use, although surgical interventions and non-surgical treatment have been the most extensively utilized procedures of periodontal treatment globally. However, in the advanced stages of periodontal disease, surgical procedures may be necessary to effectively treat the condition and prevent tooth loss. Therefore, this would create a negative impact on the global periodontal therapeutics market for the forecast period.

Periodontal Therapeutics Market Segment Analysis

The global periodontal therapeutics market is segmented based on treatment, disease type, distribution channel and region.

The Systemic Antibiotics Segment is Expected to Dominate the Global Periodontal Therapeutics Market.

In the treatment segment, the systemic antibiotics category is expected to have the highest periodontal therapeutics market share of about 54.5% for the forecast period. A variety of systemic antibiotics have been described for the treatment of periodontitis, with some studies demonstrating greater clinical results after supplementary antibiotics and others not. The Systemic antibiotics include doxycycline, metronidazole, minocycline, augmentin (amoxicillin and clavulanate) and others.

Periodontal Therapeutics Market Geographical Share

North America to Dominate the Periodontal Therapeutics Market

North America is expected to have a dominant share of around 1/3rd of this market, owing to the factors such as a growing patient pool with periodontal diseases, an increasing geriatric population and a diabetic population in the region.

For instance, according to the American Dental Association 2022 report, approximately 42% of all dentate U.S. adults 30 years of age or older are with periodontitis. On the other hand, the periodontal therapeutics market in Canada is expected to reach USD 58.66 million by 2030, as gum disease is the most common dental problem in Canadians. Owing to these reasons, the global periodontal therapeutics market share in the North American region will be sky-scraping for the forecast period.

Periodontal Therapeutics Market Key players

The major global players include Kaken Pharmaceutical Co. Ltd., Bausch Health, Colgate-Palmolive, Medicom, Pfizer Inc., 3M, Den-Mat Holdings, LLC, Dentsply Sirona, Xttrium Laboratories, Inc. and Dexcel Pharma.

COVID-19 Impact Analysis

The outbreak of COVID-19 has had a negative impact on the global periodontal therapeutics market. The sales growth of antibiotics for periodontal disease treatment slightly declined in the first half of 2020 owing to reduced hospital visits for dental services and prescriptions from dentists globally.

Russia-Ukraine Conflict Analysis

The ongoing conflict between Russia and Ukraine could potentially have an impact on the global periodontal therapeutics market, albeit indirectly. The conflict has led to economic sanctions imposed on Russia by several countries. These sanctions have had an impact on the Russian economy, which could have a ripple effect on the dental healthcare industry, including the periodontal therapeutics market.

Russia both imports and exports dental equipment, but due to the ongoing war, the supply of this equipment to other countries may be affected. Additionally, major pharmaceutical players such as Pfizer, Bayer, Sanofi and others have deferred new investments or development in the country, causing disruptions in the medicine supply chain. Consequently, this conflict has had a negative impact on the global periodontal therapeutics market.

Key Developments
• In February 2022, Envista Holdings Corporation extended its partnership contract with Vitaldent Group, a prominent Spanish Dental Service Organization (DSO), which is committed to offering patients top-notch dental care utilizing cutting-edge technology and the best treatment approaches. As a result of this agreement, Envista is now recognized as the primary supplier of implants (Nobel Biocare) and clear aligners (Spark).
• In March 2022, Biocomposites, a global medical devices firm that develops, produces, and markets cutting-edge products for bone regeneration and infection control in bone and soft tissue revealed that it has signed a multi-year partnership deal with Zimmer Biomet, a worldwide leader in medical technology. The agreement grants exclusive distribution rights for Biocomposites' geneGenexe Graft Substitute with its new mixing system and delivery options in the U.S. orthopedic market to Zimmer Biomet.
• In December 2022, The American Diabetes Association (ADA) and Pacific Dental Services (PDS) have teamed up to launch a joint Oral Health initiative that seeks to raise public knowledge about the connection between diabetes and periodontal disease (gum disease).

Why Purchase the Report?
• To visualize the global periodontal therapeutics- market segmentation based on treatment, disease type, distribution channel, and region, as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of global periodontal therapeutics market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as Excel consisting of key products of all the major players.

The Global Periodontal Therapeutics Market Report Would Provide Approximately 53 Tables, 54 Figures and 195 Pages.

Target Audience 2024
• Manufacturers / Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies